Teratogenic Drugs and Their Drug Interactions With Hormonal Contraceptives

被引：6
|
作者：
Ahn, M. R. [1 ]
Li, L. [1 ]
Shon, J. [1 ]
Bashaw, E. D. [1 ]
Kim, M-J [1 ]
机构：
[1] US FDA, Off Clin Pharmacol, Off Translat Sci, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2016年 / 100卷 / 03期
关键词：
D O I：
10.1002/cpt.384
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The US Food and Drug Administration (FDA) Guidance for IndustryDrug Interaction Studies, recommends that a potential human teratogen needs to be studied in vivo for effects on contraceptive steroids.(1) This article highlights the need to evaluate the drug-drug interactions (DDIs) between drugs with teratogenic potential and hormonal contraceptives (HCs) during drug development. It also addresses the FDA's effort of communicating DDI findings in product labels to mitigate the risk of unintended pregnancy.
引用
收藏
页码：217 / 219
页数：3
相关论文
共 50 条
  • [1] ARE HORMONAL CONTRACEPTIVES TERATOGENIC
    AMBANI, LM
    JOSHI, NJ
    VAIDYA, RA
    DEVI, PK
    FERTILITY AND STERILITY, 1977, 28 (08) : 791 - 797
  • [2] Drug interactions between hormonal contraceptives and psychotropic drugs: a systematic review
    Berry-Bibee, Erin N.
    Kim, Myong-Jin
    Simmons, Katharine B.
    Tepper, Naomi K.
    Riley, Halley E. M.
    Pagano, H. Pamela
    Curtis, Kathryn M.
    CONTRACEPTION, 2016, 94 (06) : 650 - 667
  • [3] Drug interactions between hormonal contraceptives and antiretrovirals
    Nanda, Kavita
    Stuart, Gretchen S.
    Robinson, Jennifer
    Gray, Andrew L.
    Tepper, Naomi K.
    Gaffield, Mary E.
    AIDS, 2017, 31 (07) : 917 - 952
  • [4] Drug interactions between antiretrovirals and hormonal contraceptives
    Tseng, Alice
    Hills-Nieminen, Cara
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (05) : 559 - 572
  • [5] Prescribing Hormonal Contraceptives to Women on Antiepileptic Drugs: Assessing Compendia Reporting of Drug-Drug Interactions
    Acton, Emily K.
    Decker, Barbara M.
    Willis, Allison W.
    ANNALS OF NEUROLOGY, 2019, 86 : S70 - S71
  • [6] Pharmacogenetic interactions between antiretroviral drugs and vaginally administered hormonal contraceptives
    Haas, David W.
    Cramer, Yoninah S.
    Godfrey, Catherine
    Rosenkranz, Susan L.
    Aweeka, Francesca
    Berzins, Baiba
    Coombs, Robert
    Coughlin, Kristine
    Moran, Laura E.
    Gingrich, David
    Zorrilla, Carmen D.
    Baker, Paxton
    Cohn, Susan E.
    Scarsi, Kimberly K.
    PHARMACOGENETICS AND GENOMICS, 2020, 30 (03): : 45 - 53
  • [7] Drug–Drug Interactions, Effectiveness, and Safety of Hormonal Contraceptives in Women Living with HIV
    Kimberly K. Scarsi
    Kristin M. Darin
    Catherine A. Chappell
    Stephanie M. Nitz
    Mohammed Lamorde
    Drug Safety, 2016, 39 : 1053 - 1072
  • [8] INTERINDIVIDUAL VARIATION AND DRUG-INTERACTIONS WITH HORMONAL STEROID-CONTRACEPTIVES
    BACK, DJ
    BRECKENRIDGE, AM
    CRAWFORD, FE
    MACIVER, M
    ORME, MLE
    ROWE, PH
    DRUGS, 1981, 21 (01) : 46 - 61
  • [9] THE SURVEY OF FDA APPROVED NEW MOLECULAR ENTITIES THAT ARE TERATOGENIC AND THEIR DRUG INTERACTION POTENTIALS WITH HORMONAL CONTRACEPTIVES.
    Ahn, M.
    Li, L.
    Kim, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S98 - S98
  • [10] Drug-Drug Interactions, Effectiveness, and Safety of Hormonal Contraceptives in Women Living with HIV
    Scarsi, Kimberly K.
    Darin, Kristin M.
    Chappell, Catherine A.
    Nitz, Stephanie M.
    Lamorde, Mohammed
    DRUG SAFETY, 2016, 39 (11) : 1053 - 1072
12345